President Trump's first day back in office saw him reverse former President Biden's executive order aimed at lowering prescription drug costs. While the immediate impact is unclear, critics argue that the move could allow for future price increases, putting financial strain on seniors and families.
President Donald Trump 's recent decision to rescind former President Joe Biden's executive order aimed at lowering prescription drug costs for seniors has sparked immediate controversy. Trump, on his first day back in office, signed an order reversing numerous executive actions from the Biden administration, including Biden's order, 'Lowering Prescription Drug Costs for Americans,' which directed the Department of Health and Human Services to explore strategies for cost reduction.
Biden's order led to programs within the U.S. Centers for Medicare & Medicaid Services (CMS) designed to cap the price of certain generic drugs at $2 for Medicare beneficiaries, improve Medicaid access to high-cost cell and gene therapies, and streamline the evidence-gathering process for new drugs. Democrats were swift to criticize Trump's move, accusing him of prioritizing Big Pharma over the needs of ordinary Americans. Senator Adam Schiff of California, Representative Jimmy Gomez of California, and lawyer Tristan Snell all took to social media to condemn the decision, arguing that it would result in higher out-of-pocket costs for seniors and families. While Trump's reversal of the order doesn't immediately change existing laws and regulations on prescription drug pricing, it creates uncertainty about the federal government's approach to tackling the issue. Experts suggest that the impact of Trump's decision is still unfolding and that the pharmaceutical industry's response will be crucial in determining the extent to which drug prices might rise. Some argue that the move contradicts Trump's campaign promises to lower drug prices, raising concerns about the potential for inconsistent and incoherent health policies. The long-term effects of this decision remain to be seen, but it has undoubtedly ignited a debate about the balance between corporate interests and the affordability of essential medications for millions of Americans
PRESCRIPTION DRUG PRICES DONALD TRUMP JOE BIDEN SENIOR CITIZENS HEALTH POLICY PHARMACEUTICAL INDUSTRY MEDICARE MEDICAID
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump executive order rescinds Biden's AI frameworkLawrence is a contributing reporter at Engadget, specializing in our AI overlords, musical doodads and, of course, garden variety gaming and tech. To that end, Lawrence once lost badly in multiplayer Mario to Nintendo’s own Shigeru Miyamoto, who laughed gleefully as he threw him down a pit.
Read more »
Trump rescinds Biden's census order, clearing a path for reshaping election mapsPresident Trump revoked a Biden-era executive order that affirmed the longstanding practice of including the total number of persons residing in each state in a census count used for election maps.
Read more »
Biden Rescinds Trump's Drilling Ban in Vast Federal WatersPresident Biden issued a sweeping executive order on Monday, reversing nearly 80 actions from his predecessor, Donald Trump. A key reversal was the rescission of Trump's ban on new oil and gas drilling in a significant portion of federal waters, a move that may face legal challenges. Biden's order, which came after the White House announced his intention to invoke the Outer Continental Shelf Lands Act, prohibits drilling off the coasts of the East Coast, California, Oregon, and Washington state, as well as in certain areas off Alaska and the eastern Gulf of Mexico. Existing leases and drilling operations are unaffected.
Read more »
Donald Trump rescinds Biden-era executive order on AI safetyPresident Donald Trump tossed out a Biden-era executive action order to set up safeguards for AI on his first day in office.
Read more »
Trump Rescinds Biden's AI Regulations, Embracing a Hands-Off ApproachPresident Trump's move to overturn the Biden administration's AI executive order signals a significant shift in federal oversight for the rapidly developing field of artificial intelligence. The decision raises concerns about the potential risks of unregulated AI development while proponents argue that it will foster innovation and economic growth.
Read more »
Trump Overturns Obamacare Enrollment Extension and Rescinds Biden Health Care OrdersPresident Trump reversed a policy extending the Obamacare open enrollment period in 36 states and rescinded several Biden administration executive orders on healthcare, including efforts to lower prescription drug costs and strengthen Medicaid protections. The Trump administration argues these moves address 'deeply unpopular' and 'radical' policies, while experts suggest the impact on Americans' healthcare costs will be minimal. The rescissions signal a potential shift in priorities and a reluctance to pursue Biden-era healthcare initiatives.
Read more »